AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Cefaclor Equivalent To Cefaclor Anhydrous

9 registrations across 1 African market— 7 active

Markets with Cefaclor Equivalent To Cefaclor Anhydrous

Recent registrations

Brand / ProductMarketHolderStatusExpires
VERCEF MR TABLETS🇿🇦South AfricaRanbaxy (SA) (Pty) LtdsuspendedSept 2025
CLORACEF P 125🇿🇦South AfricaUnimed Healthcare (Pty) LtdsuspendedJun 2025
RALCLOR GRANULES FOR ORAL SUSPENSION 125 mg/5 ml🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900
RALCLOR GRANULES FOR ORAL SUSPENSION 187 mg/5 ml🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900
CLORACEF PF 250🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900
RALCLOR GRANULES FOR ORAL SUSPENSION 375 mg/5 ml🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900
CLORACEF BD 375🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900
RALCLOR GRANULES FOR ORAL SUSPENSION 250 mg/5 ml🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900
CLORACEF BD 187🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900

Cefaclor Equivalent To Cefaclor Anhydrous in Africa — Regulatory Overview

Cefaclor Equivalent To Cefaclor Anhydrous is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.